Edition:
United States

ReNeuron Group PLC (RQE.L)

RQE.L on London Stock Exchange

2.20GBp
28 Apr 2017
Change (% chg)

0.05 (+2.33%)
Prev Close
2.15
Open
2.15
Day's High
--
Day's Low
--
Volume
979,025
Avg. Vol
2,434,836
52-wk High
3.71
52-wk Low
2.00

RQE.L

Chart for RQE.L

About

ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells... (more)

Overall

Beta: 0.82
Market Cap(Mil.): £69.62
Shares Outstanding(Mil.): 3,164.62
Dividend: --
Yield (%): --

Financials

  RQE.L Industry Sector
P/E (TTM): -- 58.40 30.08
EPS (TTM): -0.00 -- --
ROI: -21.57 -0.42 13.25
ROE: -21.67 5.87 14.41

More From Around the Web

Earnings vs. Estimates